Drug Patent Expirations in March 2015

Drug Patent Expirations for March 2015

TradenameApplicantGeneric NamePatent NumberPatent Expiration
SUSTIVABristol Myers Squibbefavirenz5,663,169*PEDMar 2, 2015
ATRIPLAGileadefavirenz; emtricitabine; tenofovir disoproxil fumarate5,663,169*PEDMar 2, 2015
DEPOCYTPacira Pharms Inccytarabine5,723,147Mar 3, 2015
AGENERASEGlaxosmithklineamprenavir5,723,490Mar 3, 2015
DEPODURPacira Pharms Incmorphine sulfate5,723,147Mar 3, 2015
KYNAMROGenzyme Corpmipomersen sodium6,222,025Mar 6, 2015
ENABLEXWarner Chilcott Llcdarifenacin hydrobromide5,096,890Mar 13, 2015
ADENOSCANAstellasadenosine5,731,296Mar 24, 2015
IPRIVASKMarathon Pharms Llcdesirudin recombinant5,733,874Mar 31, 2015
MIACALCINSebela Ireland Ltdcalcitonin salmon5,759,565Mar 31, 2015
ONEXTONDow Pharmbenzoyl peroxide; clindamycin phosphate5,733,886Mar 31, 2015
MIACALCINSebela Ireland Ltdcalcitonin salmon5,733,569Mar 31, 2015
ACANYADow Pharmbenzoyl peroxide; clindamycin phosphate5,733,886Mar 31, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: